Peter Earle Cestodio is a Sturbridge, Massachusetts based nurse practitioner. Active license number of Peter Earle Cestodio is RN2340032 in Massachusetts. His current practice location is 198 Charlton Rd, Sturbridge. Patients can reach him at 508-765-1600 and his NPI number (Unique professional ID assigned by NPPES) is 1780373886. Peter Earle Cestodio has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Peter Earle Cestodio speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1780373886
NPI Enumeration Date:
04 May, 2023
NPI Last Update On:
20 Mar, 2025
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Peter Earle Cestodio are as mentioned below.
License Number
Specialization
State
Status
RN2340032
Massachusetts
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Peter Earle Cestodio Po Box 415348, Boston, Massachusetts
Zip:
02241-5348
Phone Number:
800-225-8885
Fax Number:
508-334-1977
Patients can reach Peter Earle Cestodio at 198 Charlton Rd, Sturbridge, Massachusetts or can call to book an appointment on 508-765-1600.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 June, 2025.